W. V. D. van den Broek

发表

Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy Patients

S. Heymans, C. Knackstedt, G. Sinagra, 2022, Journal of the American Heart Association.

Cost-effectiveness of clopidogrel vs. ticagrelor in patients of 70 years or older with non-ST-elevation acute coronary syndrome

M. Gimbel, V. Deneer, J. T. ten Berg, 2022, European heart journal. Cardiovascular pharmacotherapy.

Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysis.

Hyo‐Soo Kim, Hyun-Jae Kang, D. Claassens, 2023, European heart journal.

Another Step Toward CYP2C19 Genotype-Guided Therapy in Treatment With Dual Antiplatelet Therapy.

J. T. ten Berg, W. V. D. van den Broek, 2023, JACC. Cardiovascular interventions.

Cost-effectiveness of clopidogrel versus ticagrelor in patients of 70 years or older with non-ST-elevation acute coronary syndrome

M. Gimbel, V. Deneer, J. T. ten Berg, 2022 .

CYP2C9 Polymorphisms and the Risk of Cardiovascular Events in Patients Treated with Clopidogrel: Combined Data from the POPular Genetics and POPular AGE Trials

J. T. ten Berg, J. Azzahhafi, W. V. D. van den Broek, 2023, American Journal of Cardiovascular Drugs.

Blood Coagulation and Beyond: Position Paper from the Fourth Maastricht Consensus Conference on Thrombosis

Richard J. Buka, C. Maas, W. Lam, 2023, Thrombosis and haemostasis.

Effects of CYP3A4*22 and CYP3A5 on clinical outcome in patients treated with ticagrelor for ST-segment elevation myocardial infarction: POPular Genetics sub-study

J. Peper, R. V. van Schaik, D. Chan Pin Yin, 2022, Frontiers in Pharmacology.

Conservative versus Invasive Strategy in Elderly Patients with Non-ST-Elevation Myocardial Infarction: Insights from the International POPular Age Registry

M. Stoel, R. Oemrawsingh, D. Chan Pin Yin, 2023, Journal of clinical medicine.

Real-World Implementation of a Genotype-Guided P2Y12 Inhibitor De-Escalation Strategy in Acute Coronary Syndrome Patients.

J. Peper, J. T. ten Berg, N. V. D. van der Sangen, 2024, JACC. Cardiovascular interventions.

The puzzle of antiplatelet therapy in ACS: ticagrelor monotherapy is another missing piece.

J. T. ten Berg, W. V. D. van den Broek, 2024, European heart journal.

The impact of patient-reported frailty on cardiovascular outcomes in elderly patients after non-ST-acute coronary syndrome.

M. Stoel, M. Gimbel, C. Runnett, 2024, International journal of cardiology.